Answers are grounded in this paper and cite their sources.
recovered in blood and nasopharyngeal swab samples (notably on day 17).Such a phenomenon has been reported in clinical trials (9,10).Further analysis is needed to distinguish genetic changes that occur in the primary viral population from apparent changes to clarify whether such escape mutants are enough to spread and persist in humans and how SARS-CoV-2 displays compartmentalized replication.Genomic surveillance for SARS-CoV-2 variants is encouraged for COVID-19 patients given mAbs as monotherapy or biotherapy.
No takes yet. Share an insight, caveat, or question.
Focosi et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: